BERGSAGEL, PL. Cyclin D dysregulation : an early and unifying pathogenic event in multiple myeloma. Blood. 2005, 106, 296-303
ZHAN, F. The molecular classification of multiple myeloma. Blood. 2006, 108, 2020-2028
SHAUGHNESSY, JD Jr. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2007, 109, 2276-2284
ZHAN, F. High-risk myeloma : a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone. Blood. 2008, 111, 968-969